Online inquiry

IVTScrip™ pSP6-VEE-mRNA-Anti-ITGA4&ITGB7, LDP-02 Vector   (CAT#: GTVCR-WQ1710MR)

This product GTVCR-WQ1710MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the SP6 promoter to efficiently generate mRNA ecoding antibody which targeting ITGA4&ITGB7 . The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter SP6
Resistance Ampicillin
Species Humanized
RefSeq NM_000885.6; NM_000889.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 3676; 3695
UniProt ID P13612; P26010
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pSP6-VEE-mRNA-Anti-ITGA4&ITGB7, LDP-02 Vector (GTVCR-WQ1710MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ2022MR IVTScrip™ pSP6-VEE-mRNA-Anti-CD19, MOR-00208 Vector Vector MOR-00208
GTVCR-WQ39MR IVTScrip™ pT7-VEE-mRNA-Anti-VEGFA, 12-IgG1 Vector Vector 12-IgG1
GTVCR-WQ1781MR IVTScrip™ pSP6-VEE-mRNA-Anti-MAPT, LY-3303560 Vector Vector LY-3303560
GTVCR-WQ1649MR IVTScrip™ pSP6-VEE-mRNA-Anti-ICOS, JTX-2011 Vector Vector JTX-2011
GTVCR-WQ340MR IVTScrip™ pT7-VEE-mRNA-Anti-PVRL4, AGS-22CE Vector Vector AGS-22CE
GTVCR-WQ278MR IVTScrip™ pSP6-VEE-mRNA-Anti-GDF11, ACE-536 Vector Vector ACE-536
GTVCR-WQ1200MR IVTScrip™ pT7-VEE-mRNA-Anti-CTGF, FG-3019 Vector Vector FG-3019
GTVCR-WQ1581MR IVTScrip™ pSP6-VEE-mRNA-Anti-KLRC1, IPH-2201 Vector Vector IPH-2201
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.